Business Unit. Performance Materials. Innovative materials. Business Line Pharmaceutical Industry India. Think Asia. Think DKSH.

Size: px
Start display at page:

Download "Business Unit. Performance Materials. Innovative materials. Business Line Pharmaceutical Industry India. Think Asia. Think DKSH."

Transcription

1 Business Unit Performance Materials Innovative materials for the pharmaceutical industry Business Line Pharmaceutical Industry India Think Asia. Think DKSH.

2 Ashland Inc., USA Polyplasdone XL (Type A) Crospovidone Conventional particle size grade Used as a disintegrant for IR tablets Polyplasdone XL-10 (Type B) Fine particle size grade Used as a disintegrant for ODT and provides smooth mouth feel Polyplasdone INF-10 (Type B) Very fine particle size grade Used as a suspending agent in oral suspension and also used as a disintegrant for pellets and MUPS Polyplasdone Ultra (Type A) Low peroxide content grade with conventional particle size Used as a disintegrant for IR tablets containing oxidation sensitive API Polyplasdone Ultra-10 (Type B) Low peroxide content grade with fine particle size Used as a disintegrant for ODT containing oxidation sensitive API Plasdone K-12 Plasdone K-17 Povidone/PVP Grade differentiation based on viscosity and K value Used as binder and vehicle for soft gelatin capsules and for drug solubilization Plasdone K-25 Plasdone K-29/32 Plasdone K-90 Plasdone K-90D Used as a binder for wet/dry granulation in tablets, capsules, pellets and powders Plasdone C-12 Plasdone C-17 Plasdone C-30 Pyrogen free grade Used as solublizer and suspension stabilizer for parenterals and ophthalmic formulations Plasdone S-630 Copovidone Plasdone S-630 is a binder and matrix polymer for solid dispersion formulations It is used to enhance solubility of poorly soluble drugs through melt extrusion or spray dried solid dispersion Klucel HF, HXF Pharm Klucel MF, MXF Pharm Klucel GF, GXF Pharm Klucel JF, JXF Pharm Hydroxypropyl cellulose (HPC) Grade differentiation based on Viscosity X' stands for fine particle size Used as a release retardant in CR Tablets and thickener for semisolids Used as a release retardant in CR Tablets and binder for solid oral formulations Klucel LF, LXF Pharm Klucel EF, EXF Pharm Klucel ELF Pharm Conventional grades used as binder for wet granulation and fine particle grade is used for dry granulation and direct compression Used in film coating system Low molecular weight Klucel used in melt extrusion 2

3 Ashland Inc., USA (Cont d) Benecel E4M Pharm* Benecel E10M Pharm* Hydroxypropyl methylcellulose/ Hypromellose (2910 substitution/ E Type) These grades can be used as hydrophilic release retardant for CR tablets Can also be used as a thickening agent to help prevent or minimize suspension settling without altering taste or mouth feel in liquid suspensions Benecel K100 LV PH PRM** Benecel K250 PH PRM** Benecel K750 PH PRM** Benecel K1500 PH PRM** Benecel K4M Pharm* Benecel K4M PH DC Benecel K15M Pharm* Benecel K15M PH DC Benecel K35M Pharm* Benecel K100M Pharm* Benecel K100M PH DC Benecel K200M Pharm* Hydroxypropyl methylcellulose/ Hypromellose (2208 substitution/ K Type) Differentiation based on viscosity 'DC' stands for direct compressible grade These grades can be used in single or in combination intragranularly or extragranularly as hydrophilic release retardant for CR tablets DC grades are used as direct compressible release retardant * CR grades available, ** Only CR grades available Benecel A15 LV PH PRM Methylcellulose Differentiation based on viscosity Benecel Methylcellulose used as granulating Benecel A15C Pharm agent and thickener. Low viscosity Benecel A15 LV is commonly Benecel A4M Pharm used in drug layering Benecel ME 233 P Pharm Aquarius Preferred HSC Aquarius Preferred HSP Aquarius Prime Aquarius Prime LS Aquarius Preferred MG Methylhydroxyethyl cellulose Ready-mix coating system It can be used as binder in solid orals and as rheology modifier in liquid orals and topicals High-solids coatings based on cellulosic polymers High-solids coatings based on copovidone with cellulosic polymers for significant improvements in adhesion and sprayable solids Coatings based on traditional cellulosic polymers Coatings based on cellulosic polymer and lactose This coating system reduces the moisture uptake 3

4 Ashland Inc., USA (Cont d) Aquarius Preferred TG Aquarius Preferred OG Aquarius Control ENA Aquarius Control SRX Ready-mix coating system This coating system masks the unpleasant taste of tablet This coating system masks the unpleasant odour of tablet Delayed-release (enteric) coatings based on methacrylic acid-ethyl acrylate copolymer Sustained release coatings based on ethylcellulose Blanose 7H4XF PH Blanose 7HF PH Blanose 7H3SF PH Blanose 7HOF PH Blanose 7M31F PH Blanose 7M8SF PH Blanose 7MF PH Blanose 7M1F PH Blnaose 7LF PH Blanose 9H4XF PH Blanose 9M31F PH Blanose 12M31P Blanose 12M8P Sodium CMC/ Carmellose sodium Differentiation based on viscosity and degree of substitution Used as a thickener/viscosity modifier in liquid orals/semi-solids Also used as a binder and release retardant for CR tablets Aqualon 7HF PH Aqualon 7H3SF PH Aqualon 7MF PH Aqualon 7M8SF PH Aqualon 7LF Aqualon 7L2P Aqualon 9M31F PH Aqualon 9M8F PH Aqualon 12M31P Sodium CMC/ Carmellose sodium Differentiation based on viscosity and degree of substitution Used as a thickener/viscosity modifier in liquid orals/semi-solids Also used as a binder and release retardant for CR tablets Aqualon EC T10 Pharm Ethyl cellulose Differentiation based on viscosity Used as a binder in direct compression due to its good flow and compactability Aqualon EC N7 Pharm Aqualon EC N10 Pharm Aqualon EC N14 Pharm Aqualon EC N22 Pharm Aqualon EC N50 Pharm Aqualon EC N100 Pharm Used for coating powder, granules and pellets to control drug release. Also used in seal coating 4

5 Ashland Inc., USA (Cont d) Natrosol 250 HHX/HHW Pharm Natrosol 250 HX Pharm, H Pharm Natrosol 250 M Pharm Natrosol 250 G Pharm Natrosol 250 L Pharm Hydroxyethyl cellulose Differentiation based on viscosity 'X' stands for fine particle size Used as a viscosity modifier in liquid orals and semi-solids Also used as release retardant in CR tablets Aquasolve L Hypromellose Dissolves at ph more than 5.8 Aquasolve M acetate succinate/hpmcas Dissolves at ph more than 6.0 Aquasolve H Dissolves at ph more than 6.8 Used as an enteric coating agent and as a solublizer for poorly soluble API in spray dried solid dispersions and hot melt extrusion Cavamax W6 Pharma a-cyclodextrin Oral grade Used to enhance solubility of Cavamax W7 Pharma b-cyclodextrin poorly soluble drugs in solid dispersions Cavamax W8 Pharma Used to mask unpleasant odour/ g-cyclodextrin taste of API and to stabilize the Cavasol W7 HP Pharma Hydroxypropyl b-cyclodextrin same Cavasol W8 HP Pharma Hydroxypropyl g-cyclodextrin Cavitron W7 HP5 Pharma Cavitron W7 HP7 Pharma Hydroxypropyl b-cyclodextrin Parenteral grade Used to increase solubility of drug in Parenterals Pharmasolve N-methyl-2- pyrrolidone Used as solubilizer and penetration enhancer in parenterals and topicals Crest Cellulose Pvt. Ltd., India Cellucrest 101 Microcrystalline cellulose Conventional particle size grade Conventional grade for wet and dry granulation Cellucrest 102 Coarser particle size Filler for direct compression. Improves flow property and compressibility Cellucrest 112 Low moisture, coarser particle size Filler for direct compression of moisture sensitive product Cellucrest 113 Low moisture, fine particle size Improves stability of moisture sensitive product 5

6 Crest Cellulose Pvt. Ltd., India (Cont d) Cellucrest 200 Microcrystalline cellulose Largest particle size Improves flow of blend for direct compression and dry granulation. Also reduces weight variation and variation in content uniformity Cellucrest 301 High bulk density grade To achieve efficient mixing of blend to manufacture small tablets and reduces weight variation and variation in content uniformity Cellucrest 302 High bulk density grade with coarser particle size To achieve efficient mixing of blend to manufacture small tablets and reduces weight variation and variation in content uniformity Rapigel Sodium starch glycolate Used as a disintegrant for IR tablets, capsules and ODT Lubricrest Magnesium stearate Lubricant Crestcross Crestadd Gelmac Croscarmellose sodium Dicalcium phosphate anhydrous/ Dicalcium phosphate dihydrate Pregelatinized maize starch Used as a disintegrant for IR tablets, capsules and ODT Used as a filler in wet granulation Used as a binder Symega Flavours, India Flavor (Liquid form) Spray Dried Flavor (Powder form) Bitter Taste Masker Natural flavor Nature identical flavor Synthetic flavor Flavoring agent for liquid orals Flavoring agent for ODT, effervescent powder, granules and tablets Unique combinations for bitter taste masking Functional Flavor Delivery of nutraceutical actives for gut health 6

7 Stepan, USA Stepanol WA 100 Sodium lauryl sulphate Oral grade, needle like crystals Used as a wetting agent in tablets, liquid orals and semi-solids Mondo Minerals B.V., Netherlands Microtalc Pharma 50 Talc/Hydrated Standard Particle Size grade Used as an antiadherant for tablets Microtalc Pharma 30 Microtalc Pharma 8 Magnesium Silicate Fine particle size grade Very fine particle size grade Used for drug layering in pellets and also used as anti tacking agent in film coating system JMC Corporation, Korea Sodium saccharin, 15% moisture Sodium saccharin, 6% moisture Sodium saccharin Used as a sweetner in powder, granules, ODT and liquid orals Precheza A.S., Czech Republic Pretiox AV 01 PhG Titanium dioxide Used as an opacifier in capsule shell and color coating system 7

8 Freund Corporation, Japan Dilactose R Dilactose F Dilactose S Lactose monohydrate (Granulated) Grade differentiation based on particle size Used in direct compression formulations to provide good flow and superior compressibility. Tablets manufactured with Dilactose provides quick disintegration Daicel Corporation, Japan GNF-D211 GNF-D215 Co-Processed excipient (D-Mannitol, Microcrystalline cellulose, Crospovidone, Carboxymethyl cellulose) Co-processed excipient for ODT Kimica Corporation, Japan Kimica Acid SN Kimica Acid SEB Alginic acid Complying NF (National Formulary) Complying to EP and BP Used as a disintegrant in anti-reflux and effervescent tablets Kimica Algin ULV-L3 Kimica Algin ULV-L5 Kimica Algin ULV-1 Kimica Algin ULV-3 Kimica Algin ULV-5 Sodium alginate Ultra low viscosity sodium alginate Used as a gelling agent in anti-reflux suspensions and effervescent tablets Kimica Algin IL-2 Kimica Algin IL-6 Kimica Algin I-1 Kimica Algin I-3 Kimica Algin I-5 Kimica Algin I-8 Kimica Algin I-S Sodium alginate Standard type sodium alginate Used in controlled release formulations 8

9 Kimica Corporation, Japan (Cont d) Kimica Algin LZ-2 Sodium alginate Ultra high viscosity sodium alginate Used in controlled release formulations Kimica Algin ULV-1G Kimica Algin ULV-5G Kimica Algin IL-6G Kimica Algin I-1G Kimica Algin I-3G Sodium alginate High stiffness gelation type Sodium Alginate Kimiloid LVC Kimiloid HVC Propylene glycol alginate Standard Type Propylene Glycol Alginate Used as a suspending agent, emulsion stabilizer, plasticiser and binder Kimiloid AB Kimiloid LLV Kimiloid NLS-K Kimiloid LV Kimiloid MV Kimiloid HV High esterification type Propylene Glycol Alginate Kimica Algin K Potassium alginate Dental impression material Kimica Algin Ca Calcium alginate Gelling agent Kimica Algin NH Ammonium alginate Dental impression material Kimica Algin Mag Magnesium alginate Anti reflux suspensions for infants NOF Corporation, Japan NOF CORPORATION Polysorbate 20 Polysorbate 80 GS Polysorbate 80 HX2 Polyoxyethylene sorbitan monolaurate/polysorbate 20 Polyyoxyethylene Sorbitan monooleate/polysorbate 80 Used as a solublizer in parenterals Used as a solublizer in parenterals High purity solubilizer for parenterals Sunbright DKH-02HB PEG 200 Parenteral grade Used as a solublizer in parenterals Sunbright DKH-03HB PEG 300 Sunbright DKH-04HB PEG 400 Activated PEGs Methoxy-polyethylene glycols (mpegs) Used for targeted drug delivery system 9

10 NOF Corporation, Japan (Cont d) NOF CORPORATION Phospholipids from Natural Sources Synthetic Phospholipids HSPC (Hydrogenated soyabean phosphatidylcholine EPC (Egg phosphatidylcholine) HEPC (Hydrogenated egg phosphatidylcholine) Egg sphingomyelin/ Milk sphingomyelin Different derivatives of phosphocholine Different derivatives of phosphatidylglycerol Different derivatives of phosphatidic acid, sodium salts Different derivatives of phosphotidylethanolamine Different derivatives of phosphatidylserine Used in liposomes Used in liposomes Fresenius Kabi, Germany Purified Egg Phospholipids PL 90 Purified egg phospholipids Parenteral grade Used as an emulsifier in injectables Wacker Chemie AG, Germany Cavamax W8 - CoQ10 complex Highly bioavailable CoQ10 Cardiovascular health 10

11 Wacker Chemie AG, Germany (Cont d) Cavacurcumin Highly bioavailable curcumin Anticancer/antiinflammatory HTEssence Hydroxytyrosol Antioxidant for Cardiovascular health/ skin lightening Horphag Research, Switzerland Pycnogenol French maritime pine bark extract Cardiovascular health Improves endothelial function Normalises high blood pressure Diabetes Joint health Oral skin care/topical skin care Sports nutrition Erectile dysfunction Robuvit French oak extract Chronic fatigue syndrome Clariant, Switzerland Polyglykol 300 Polyglykol 400 Polyglykol 600 Polyethylene glycols/ Macrogols Brand name followed by numbers indicate the average molecular weight The high solvent power leads to a broad use of low molecular weight PEGs in liquid preparations such as drops, parenterals or fillings for gelatin capsules Polyglykol 1000 Polyethylene glycols/ Macrogols Used to make ointment base Lanogen 1500 Polyethylene glycols/ Macrogols Ointment base (JP) containing Polyglykol 300 and 1500 in a ratio of 1:1. Used as an ointment base 11

12 Clariant, Switzerland (Cont d) Polyglykol 1500 S Polyglykol 2000 S Polyglykol 3000 S/P Polyglykol 3350 S/P/PS Polyglykol 4000 S/P/PF/ PS Polyglykol 6000 S/P/PF Polyglykol 8000 S/P/PF Polyglykol S/P Polyglykol S/P Polyglykol S/P Polyglykol S Polyethylene glycols/ Macrogols Brand name followed by numbers indicate the average molecular weight S' stands for flakes 'P' stands for powder 'PF' stands for fine powder 'PS' stands for spray dried powder Solid PEGs are preferred bases for suppository masses. PEGs can be used as carriers, solubilizers and absorption improvers for active substances, usually processed in the form of a melt (melt granulation) They also act as lubricants and binders during tablet processing PEGs also has a plasticizing effect which facilitates the shaping of the tablet mass in the compression process and may counteract capping Solid PEGs are also frequently used in tablet coatings as a plasticizer. The flexibility of sugar-coated tablets is increased by PEGs The USP/NF describes a blend in the monograph PEG 3350 and Electrolytes for Oral Solution as a laxative preparations which contains a detailed description of all potential individual salt components to be used in addition to the polyglycol with a mean molecular weight of 3350 Ingredion, USA Farmal MN 5000 Mannitol Standard oral grade Used as a diluent for ODT and also used in sugar free tablets Farmal MN 5010 Injectable grade Vehicle for lyophilised products Dulcent Aspartame Aspartame Used as a sweetner in powder, granules, ODT and liquid orals Dulcent Sucralose Sucralose Used as a sweetner in powder, granules, ODT and liquid orals 12

13 Our core business Pharmaceutical industry We source and supply a wide range of innovative, high-performance chemicals, intermediates, API and formulations for the pharmaceutical industry. Sourcing We source APIs, excipients, and intermediates from India as well as globally. We provide Regulatory support Technical assistance Logistics, warehousing and distribution Custom manufacturing Development services Quality assurance Strengthen service offerings We continually strengthen and expand our range of service offerings across the entire value chain. To ensure the long-term success of our business partners, we constantly deliver more value-added solutions that give them a competitive advantage. Your preferred partner for sourcing Comprehensive sourcing network in Asia, Europe and the Americas Proven track record Early trend scout Global technology transfers Highly dedicated team of sourcing specialists Increase operational efficiency We continuously improve the efficiency of our processes. The quality of our services is based on best practices and standards throughout our entire organization. An efficient supply chain coupled with synergies across all Business Units and countries allow us to fulfill the diverse requirements of the business we serve. Our key sourcing offices Japan Korea China India Europe The information in this brochure is to our best knowledge true and accurate but, all instructions, recommendations or suggestions are made without guarantee. Since the conditions of use are beyond their control, DKSH disclaims any liability for loss or damage suffered for use of this data or suggestions. Furthermore, no liability is accepted if use of any product in accordance with this data or suggestions infringes any patent. 13

14 Notes 14

15 15

16 Pharmaceutical industry Branch locations Ahmedabad Phone Kolkata Phone Delhi Phone /21 Mumbai Phone DKSH India Private Limited Fantree Building, Sarla Park, Andheri East, Mumbai , India Phone , Fax Secunderabad Phone

we ve got you covered pharmaceutical product and solution guide

we ve got you covered pharmaceutical product and solution guide we ve got you covered pharmaceutical product and solution guide 2 / we ve got you covered Helping to ensure the efficacy, integrity and usability of pharmaceutical formulations At Ashland, our number one

More information

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies VIVAPHARM PVP/VA Copovidone, Ph.Eur. USP/NF, JPE, E 1208, FCC The Ultimate Tablet Binder for All Processing Technologies Direct Compression Dry Granulation Hot Melt Extrusion Wet Granulation VIVAPHARM

More information

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019

More information

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant EXCIPIENTS STARCH 1500 Proven and Trusted Excipient for Performance and Versatility Effective and economical disintegrant Excellent stability for moisture sensitive drugs Manufactured exclusively for the

More information

Easy, fast and reliable!

Easy, fast and reliable! Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. Tailormade formulated. s film coating products are one-step coating

More information

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets. PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-029-1 (Supersedes PTR 029) Page 1 of 7 Hydroxypropylcellulose in Modified Release Matrix Systems: Polymer Molecular Weight Controls

More information

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Critical material properties for the design of robust drug products : excipient functionality related characteristics Critical material properties for the design of robust drug products : excipient functionality related characteristics Dr Liz Meehan, Pharmaceutical Development, Macclesfield UK 1 Excipients Definition

More information

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER Life-saving pharmaceuticals start with high-quality ingredients CONFIDENCE STRAIGHT FROM THE SOURCE From oral dosage excipients (Rx, Gx, nutraceuticals

More information

Easy, fast and reliable!

Easy, fast and reliable! Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. s film coating products are one-step coating systems for pharmaceutical

More information

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig PHARMACEUTICAL THNOLOGY REPORT Consumer Specialties ashland.com PTR 11 Page 1 of 5 Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig Objectives When preparing tablets by roller

More information

FLORITER. New Technology for Innovative Formulation Design.

FLORITER. New Technology for Innovative Formulation Design. FLORITER New Technology for Innovative Formulation Design www.tomitaph.co.jp FLORITE Dramatically Change Your Formulation FLORITE is synthetic Calcium Silicate with exceptional liquid absorbency and excellent

More information

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations TECHNICAL INFORMATION 1426 RxCIPIENTS FM 1 A versatile excipient for orally disintegrating tablet (ODT) formulations Table of contents 1 Introduction 3 2 Mode of action and advantages of RxCIPIENTS FM

More information

Etat des travaux du GDP

Etat des travaux du GDP Etat des travaux du GDP (Avril 2018) Item General methods relevant to Q6A Dissolution (rev. 3) 4 Disintegration (rev. 1) 4 Uniformity of content/mass (rev. 2, corr. 1) 4 Tests for specified microorganisms

More information

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients LubriTose Mannitol Michael Crowley, Director of R&D, Excipients Introduction Michael Crowley Director of R&D Excipients 158 St. Highway 320 Norwich, NY 13815 PH 315-802-5970 Michael.Crowley@Kerry.com 2

More information

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical Excipient Quality & Trouble Shooting By Seema Trivedi GM, Technical Back Ground The Society for Pharmaceutical Dissolution Science (SPDS) had held its 6th Annual International Convention Disso India -

More information

ORAL DOSAGE OVERVIEW

ORAL DOSAGE OVERVIEW ORAL DOSAGE OVERVIEW AN UNWAVERING COMMITMENT TO ENABLING LIFE-SAVING PHARMACEUTICALS The safety of your patients is your number one priority. That s why the quality and stability of your formulations

More information

Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples

Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples Guidance on Pharmaceutical Excipient Suitability Studies (PESS) with Chinese Pharmacopeia (Volume 4): Basics and Examples Professor Jiasheng Tu, Ph. D. France 2018/09 content 1 Introduction 2 PESS guidance

More information

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2010/39 (19) (12) EUROPEAN PATENT APPLICATION (11) EP 2 233 131 A1 (43) Date of publication: 29.09. Bulletin /39 (1) Int Cl.: A61K 9/ (06.01) A61K 31/00 (06.01) (21) Application number: 09908.8 (22) Date of filing:

More information

REVISION OF MONOGRAPH ON TABLETS. Tablets

REVISION OF MONOGRAPH ON TABLETS. Tablets March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-8 Page 1 of 6 Are Cellulosic Controlled Release Technologies Vulnerable to Dose Dumping in Ethanolic Dissolution Media? Elanor Pinto,

More information

METOLOSE: CONTENTS PAGE

METOLOSE: CONTENTS PAGE METOLOSE: CONTENTS PAGE 2 Preface What is Metolose Substitution types Specifications 1) Available grades & viscosity 2) Nomenclature 3) Packaging Characteristics of Metolose Properties of Metolose 1) Powder

More information

TABLET DESIGN AND FORMULATION

TABLET DESIGN AND FORMULATION TABLET DESIGN AND FORMULATION PART 5 Industrial pharmacy 5th class 1st semester TABLET DESIGN AND FORMULATION Conventional oral tablets for ingestion usually contain the same classes of components in addition

More information

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION LEARNING OBJECTIVES The objectives of this unit are to: Understand the formulation of solid dosage form. Understand the characteristic

More information

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications Hypromellose CONTENTS PAGE 2 Preface Matrix system Selection of METOLOSE grades Specifications Properties Powder Solution Application Related Patents 3 4-5 6 8 10 13 14 17 Please note: The information

More information

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ QbD Approach to Formulation of Hydrophilic Matrix Using Sample Kit of Hypromellose [Metolose SR] DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa,

More information

Formulation and Evaluation

Formulation and Evaluation Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the

More information

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY Excipients are inactive ingredients used as carriers for the active ingredients in a pharmaceutical product. These may

More information

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Dow Wolff Cellulosics Pharmaceutical Excipients Using ingenuity and savvy to help design healthcare solutions TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Enhancing

More information

SENTRY TM POLYOX Water Soluble Resins

SENTRY TM POLYOX Water Soluble Resins SENTRY TM POLYOX Water Soluble Resins Technical Information on Stability Introduction Key Points Antioxidants SENTRY POLYOX WSR resins consist of a family of high molecular weight polyethers with nominal

More information

Animal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation

Animal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation Animal Health Product Overview Liquids and Gels Solid Dosage Forms Premixes Dietary Fibers Customize Your Formulation ANIMAL HEALTH Product Overview General Information Liquids and Gels Healthcare is essential

More information

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2. EXCIPIENTS PROFILES ANNEXURE -2 Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2.1. COMPRITOL 888 Non proprietary names BP:

More information

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating LYCOAT New solutions for Film Coating from Roquette LYCOAT for quicker quality coating Roquette LYCOAT New solutions for Film Coating from Roquette LYCOAT New solutions for Film Coating Film coating, the

More information

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy Dr. Philipp Hebestreit, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.

More information

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015 Dr. Susanne Keitel Director EDQM, Council of Europe Outline 1. The European Pharmacopoeia 2. The importance of

More information

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 Innovations in Design: NIA-West Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 1 Innovations in Design: How Do You Stand Out? If all other competitors are the same

More information

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION (19) (11) EP 1 864 677 B1 (12) EUROPEAN PATENT SPECIFICATION (4) Date of publication and mention of the grant of the patent: 02.01.08 Bulletin 08/01 (1) Int Cl.: A61K 38/ (06.01) A61K 9/ (06.01) A61K 31/39

More information

Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE

Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE Paradigm shift in pharmaceutical development Traditional medicinal products

More information

SUMMARY AND CONCLUSION

SUMMARY AND CONCLUSION SUMMARY AND CONCLUSION 8 SUMMARY AND CONCLUSIONS In spite of the many challenges faced by researchers while designing an effective, reproducible and stable dosage form, oral dosage forms continued to maintain

More information

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels Seite 1 von 8 Share this story: Issue: April 2015, Posted Date: 3/30/2015 FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels INTRODUCTION Soft gelatin capsules (softgels) continue

More information

Pharmaceutical Preparation For Internal Use

Pharmaceutical Preparation For Internal Use Pharmaceutical Preparation For Internal Use 1. Solid Preparations (Tablet, Capsule, Pill) 2. Liquid Preparations (Aqua, Syrup, Elixir, Extract, Liquor, Emulsion, Mixture, Infusion, Decoction). 3. Powder

More information

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009 Co-Processed Excipients: Regulatory Challenges Carl Mroz Colorcon Limited June 2009 What is a Co-Processed excipient? Several types of excipient contain multiple components by design Use of processing

More information

LAB.2. Tablet Production Methods

LAB.2. Tablet Production Methods LAB.2 Tablet Production Methods Dry methods Direct compression Dry granulation Wet methods Wet granulation Regardless whether tablets are made by direct compression or granulation, the first step, milling

More information

Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig

Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-069-1 (Supersedes PTR-069) Page 1 of 8 Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems

More information

PHARMACEUTICAL TECHNOLOGY REPORT. Abstract Summary. Introduction. Experimental Methods. Consumer Specialties ashland.com

PHARMACEUTICAL TECHNOLOGY REPORT. Abstract Summary. Introduction. Experimental Methods. Consumer Specialties ashland.com PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-037-3 (Supersedes PTR-037-2) Page 1 of 7 Hydrodynamic Robustness of Hypromellose and Hydroxypropyl Cellulose Based Modified Release

More information

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( ) (19) TEPZZ 94677_A_T (11) (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 2.11.1 Bulletin 1/48 (1) Int Cl.: A61K 9/ (06.01) A61K 31/41 (06.01) (21) Application number: 116790.3 (22) Date of

More information

SCIENTIFIC DISCUSSION. Efavirenz

SCIENTIFIC DISCUSSION. Efavirenz SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredient (API): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:

More information

Table 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type

Table 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-046-1 (Supersedes PTR-046) Page 1 of 6 Effect of Hypromellose and Methylcellulose Substitution Type, Molecular Weight and Drug Solubility

More information

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose 1 Pharmaceutical industry borrowed ingredients from other industries Food Cosmetic Industrial Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work that has all changed

More information

PRESS RELEASE. Food Ingredients Asia 2013: WACKER Showcases Highly Bioavailable Curcumin. Number 51

PRESS RELEASE. Food Ingredients Asia 2013: WACKER Showcases Highly Bioavailable Curcumin. Number 51 Wacker Chemie AG Hanns-Seidel-Platz 4 81737 München, Germany www.wacker.com PRESS RELEASE Number 51 Food Ingredients Asia 2013: WACKER Showcases Highly Bioavailable Curcumin Munich/Bangkok, September 11,

More information

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability Andreas Gryczke, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.

More information

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,

More information

Challenges and solutions for moisture sensitive API formulation

Challenges and solutions for moisture sensitive API formulation Challenges and solutions for moisture sensitive API formulation Introduction Today, formulators are looking for alternative processes to reformulate existing products or to formulate New Chemical Entities

More information

Formulation Study for Lansoprazole Fast-disintegrating Tablet. II. Effect of Triethyl Citrate on the Quality of the Products

Formulation Study for Lansoprazole Fast-disintegrating Tablet. II. Effect of Triethyl Citrate on the Quality of the Products September 2003 Chem. Pharm. Bull. 51(9) 1029 1035 (2003) 1029 Formulation Study for Lansoprazole Fast-disintegrating Tablet. II. Effect of Triethyl Citrate on the Quality of the Products Toshihiro SHIMIZU,*

More information

Kollicoat Smartseal 30 D Active Protection

Kollicoat Smartseal 30 D Active Protection Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active Ingredients Kollicoat Smartseal 3 D Active Protection Breaking new ground in taste masking and moisture

More information

The unlocked synergy of DFE Pharma MCC

The unlocked synergy of DFE Pharma MCC The unlocked synergy of DFE Pharma MCC We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation formulations.

More information

02/09/2016. Roles of Excipients in Pharmaceuticals:

02/09/2016. Roles of Excipients in Pharmaceuticals: Definition: Any substance other than the active drug or prodrug that is included in the manufacturing process or is contained in a finished pharmaceutical dosage form. Excipients are not inactive and have

More information

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence YOUR ORAL SOLID DOSE DFE Pharma globally supplies a unique, broad portfolio of key excipients including lactose, MCC, superdisintegrants and starches. Innovative products such as SuperTab 24AN and SuperTab

More information

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process Direct With the right ingredients it s a simple, cost-effective manufacturing process TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Speed and savings sounds good to us

More information

TEPZZ Z697_5A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/20 ( ) A61K 31/135 (2006.

TEPZZ Z697_5A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/20 ( ) A61K 31/135 (2006. (19) TEPZZ Z697_A_T (11) EP 3 069 7 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 21.09.16 Bulletin 16/38 (1) Int Cl.: A61K 9/ (06.01) A61K 31/13 (06.01) (21) Application number: 160172.1

More information

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy

Principals and Dosage Forms in the Therapy Modified Drug Release. Institute of Pharmaceutical Technology and Biopharmacy Principals and Dosage Forms in the Therapy Modified Drug Release Institute of Pharmaceutical Technology and Biopharmacy Dosage forms Definition: Dosage forms are the means by which drug molecules are delivered

More information

Functional Excipients for Suppository Applications

Functional Excipients for Suppository Applications Functional Excipients for Suppository Applications Skin Delivery Platform 2016 1 The Skin Delivery Platform Major areas of activity are in 4 pillars PLATFORM : SKIN DELIVERY Dermal Drug Delivery Mildness

More information

Soluplus The Solid Solution Opening New Doors in Solubilization.

Soluplus The Solid Solution Opening New Doors in Solubilization. Soluplus The Solid Solution Opening New Doors in Solubilization. Dr. Shaukat Ali, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active

More information

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products 57. Starch Convention, Detmold, April 26-28, 2006 K.-J. Steffens Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products Starches, Pharmaceutical Applications _ Starches

More information

Rationale of and Experience with the Expert System

Rationale of and Experience with the Expert System Rationale of and Experience with the Expert System Professor Mitsuru HASHIDA Roland DAUMESNIL Lecture presented during the Controlled Release Society Symposium Optimization of Oral Drug Delivery Hong Kong

More information

Non-Food Uses of Polysaccharides

Non-Food Uses of Polysaccharides Non-Food Uses of Polysaccharides John Mitchell John.Mitchell@biopolymersolutions.co.uk Acknowledgements Fundamentals of Hydrocolloid Technology Course (2003-2009) Rob Winwood Colin Melia Steve Harding

More information

ZHONGBAO CHEMICALS CO.,LTD

ZHONGBAO CHEMICALS CO.,LTD ZHONGBAO CHEMICALS CO.,LTD HANGZHOU ZHONGBAO IMP & EXP CORP.,LTD SINCE 1963 An ISO9001:2000 company Zhongbao Chemicals Co.,LTD is one of the world s specialty chemical companies-including manufacturing

More information

CAPMUL + CAPTEX + ACCONON = SEDDS

CAPMUL + CAPTEX + ACCONON = SEDDS OUR SOLUTIONS PORTFOLIO ABITEC products are specifically designed for meeting the solubility challenges of the pharmaceutical industry. Our products can be used alone or in conjunction with one another

More information

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*

More information

( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1

( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1 THE LETTERIN US 20170231969A1 MUTTU 19 United States ( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / 0231969 A1 Raneburger et al. ( 43 ) Pub. Date : Aug. 17, 2017 ( 54 ) PHARMACEUTICAL

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1

More information

CHEWABLE SOFTGEL TECHNOLOGY

CHEWABLE SOFTGEL TECHNOLOGY CHEWABLE SOFTGEL TECHNOLOGY PROCAPS AT A GLANCE Procaps is a Pharmaceutical Group dedicated to delivering innovation, health and Nutrition. We work hand in hand with our customers and develop products

More information

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M.

Short Communication. Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L. J. TIROP AND K. A. M. 61 East and Central African Journal of Pharmaceutical Sciences Vol. 18 (2015) 61-66 Short Communication Formulation of Furosemide Dispersible Tablets for Use in Paediatrics V. V. ABWOVA, P. N. MBEO, L.

More information

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY

DRY SYRUPS SWAPNA.M. Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL SEMINAR BY DRY SYRUPS SEMINAR BY SWAPNA.M M.PHARMACY Ist semester DEPARTMENT OF PHARMACEUTICS UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES KAKATIYA UNIVERSITY, WARANGAL CONTENTS DEFINITION CHARACTERISTICS OF SUSPENSIONS

More information

Public Assessment Report. Scientific discussion. Venlafaxin SUN 37.5 mg, 75 mg and 150 mg prolonged-release tablets. (venlafaxine hydrochloride)

Public Assessment Report. Scientific discussion. Venlafaxin SUN 37.5 mg, 75 mg and 150 mg prolonged-release tablets. (venlafaxine hydrochloride) Public Assessment Report Scientific discussion Venlafaxin SUN 37.5 mg, 75 mg and 150 mg prolonged-release tablets (venlafaxine hydrochloride) NL/H/3948/001-003/DC Date: 6 January 2016 This module reflects

More information

Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M. Super-disintegrants and dissolution enhancers.

Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M. Super-disintegrants and dissolution enhancers. Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M Super-disintegrants and dissolution enhancers. 2 The Preface New: 4 dimensions of Kollidon CL standard, fine (CL-F), superfine (CL-SF) and micronized

More information

Texturizing Solutions: Serving customers across categories

Texturizing Solutions: Serving customers across categories Texturizing Solutions: Serving customers across categories Starches Soy* Lecithin Hydrocolloids** FS Bakery Beverage Confectionery Convenience foods Dairy Fruit Infant and Baby food Meat Petfood native

More information

Food supplement manufacture

Food supplement manufacture Food supplement manufacture Nick Bennett BSc. RNutr April 2018 1 Introduction There are many different product formats available Liquids, powders, tablets, capsules etc Many different types of machine

More information

USP Excipients Standards Setting Process

USP Excipients Standards Setting Process USP Stakeholder Forum, Meeting #1 June 7, 2013 USP Excipients Standards Setting Process Catherine M. Sheehan, M.S., M.S. Sr. Director, Excipients US P Convention cxs@usp.org Historical Background on the

More information

Folic Acid in Human Nutrition

Folic Acid in Human Nutrition Folic Acid in Human Nutrition Folic acid is a water soluble B vitamin widely distributed in foods. Deficiencies lead to impaired cell division and altered protein synthesis. Newborn children of women receiving

More information

I International Bureau (10) International Publication Number (43) International Publication Date

I International Bureau (10) International Publication Number (43) International Publication Date (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International

More information

Large scale production

Large scale production Large scale production Rotary capsule machine: This machine has two, side-by-side cylinders in each of which half-moulds are cut. These cylinders, like the rollers of a mangle, rotate in contrary direction

More information

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION 1 PHARMACEUTICS Pharmaceutics is the science of dosage form design. The general area of study concerned with the formulation, manufacture, stability, and

More information

3. Drug or plant or excipients profile

3. Drug or plant or excipients profile 3. Drug or plant or excipients profile 3. 1 Analysis of Reference Listed Drug (RLD) Product ABILIFY (aripiprazole) 3.1.1 Clinical The Reference Listed Drug (RLD) is Brand ABILIFY (aripiprazole) Tablets

More information

AnyCoat. From Nature, Beside you.

AnyCoat. From Nature, Beside you. AnyCoat From Nature, Beside you www.lotte-cellulose.com 04 AnyCoat is 05 Certificates of AnyCoat AnyCoat-C 06 General Characteristics 07 Specifications 08 Chemical Structure, Nomenclature 09 Functional

More information

The binding performance of DFE Pharma Starch

The binding performance of DFE Pharma Starch The binding performance of DFE Pharma Starch MCC Starch Lactose Inhalation Superdisintegrants We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients

More information

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore 1 REGULATORY PERSPECTIVE Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore Contents 2 1. Role of Dissolution Testing in Generic Drug Approval 2. Dissolution Testing Recommendation for Solid Oral

More information

Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R. Lewis, B. Kinsey and T. Dürig*

Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R. Lewis, B. Kinsey and T. Dürig* PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-039-2 (Supersedes PTR-039-1) Page 1 of 9 Evaluation of Moisture Sorption Methods for Aqueous Moisture Barrier Coatings D. Tewari, R.

More information

EUDRAGIT L 100 and EUDRAGIT S 100

EUDRAGIT L 100 and EUDRAGIT S 100 Technical Information EUDRAGIT L 100 and EUDRAGIT S 100 Specification and Test Methods Ph. Eur. Methacrylic Acid - Methyl Methacrylate Copolymer (1:1) Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)

More information

GLYCOLYS

GLYCOLYS ROQUETTE WORLDWIDE EUROPE FRANCE Roquette Frères Corporate Headquarters 62080 Lestrem cedex - France Telephone: + 33 3 21 63 36 00 Fax: + 33 3 21 63 38 50 FINLAND Roquette Nordica Oy PL 11 P.O.B FIN-02171

More information

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives

Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives Paper No.: 13 Paper Title: Food Additives Module 2. Functional Classification of Food Additives 2.1 Introduction According to the Food Protection Committee of the Food and Nutrition Board, food additives

More information

Why and how does a pharmaceutical company take the risk to use novel excipients?

Why and how does a pharmaceutical company take the risk to use novel excipients? Why and how does a pharmaceutical company take the risk to use novel excipients? M. Sherry Ku, Ph.D. CSO, Anchen Pharmaceuticals Irvine, CA Excipient Fest, May 5, 2010 Puerto Rico Global Excipient Acceptability

More information

FORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL

FORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY Available online at www.ijrpc.com Research Article FORMULATION AND EVALUATION OF THEOPHYLLINE BILAYERED TABLETS USING HPC AS MATRIX MATERIAL

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:

More information

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester 5/21/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 1 Outlines Why rectal or vaginal route? Suppository

More information

Baerlocher Additives for PVC. Lubricants

Baerlocher Additives for PVC. Lubricants Baerlocher Additives for PVC Lubricants we add character to plastics The Baerlocher Group of Companies is one of the world s leading suppliers of additives for the plastics industry with a strong focus

More information

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.

More information

Formulation and evaluation of oro-dispersible tablets of lafutidine

Formulation and evaluation of oro-dispersible tablets of lafutidine Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Technical brochure StarLac

Technical brochure StarLac T R TABLETING AC DIRECT COMPRESSION CO-PROCESSED LACTOSE Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture is

More information

Designed and manufactured specifically for pharmaceutical capsule filling

Designed and manufactured specifically for pharmaceutical capsule filling EXCIPIENTS Designed and manufactured specifically for pharmaceutical capsule filling Simple formulation Superior flow and weight uniformity Clean and efficient processing This document is valid at the

More information

Formulation Development of Etoricoxib Tablets by Wet Granulation and Direct Compression Methods Employing Starch Phosphate

Formulation Development of Etoricoxib Tablets by Wet Granulation and Direct Compression Methods Employing Starch Phosphate International Journal of Pharmacology and Technology 3(1), June 2011, pp. 9-15 Formulation Development of Etoricoxib Tablets by Wet Granulation and Direct Compression Methods Employing Starch Phosphate

More information